Delivery Order SPE2DB25D2203-SPE2DB25FPSCM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,154.68 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,028.84 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's established capability to supply critical pharmaceutical...
- The Defense Logistics Agency awarded a $38,088.74 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of June 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a $10,640.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick autoinjectors, with performance at the contractor's facility in Conshohocken, Pennsylvania. This non-competitive delivery order was awarded on May 30, 2025, with an ultimate completion date of June 2, 2025. The award represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and serves military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $112,020.29 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on June 3, 2025, with an ultimate completion date of June 4, 2025, represents a non-competitive, competitively awarded transaction under an existing contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $83,040.50 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order was issued on June 26, 2025, with an ultimate completion date of June 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,289.83 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price, competitively awarded contract is a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by July 25, 2025, and will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,543.12 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a $35,072.01 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is listed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,459.45 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price, non-set-aside delivery order is expected to be completed by June 6, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive...
- SPE2DB25D2203Indefinite Delivery Contract
- SPE2DB25D2203-SPE2DB25FPSCMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,238.77 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery order. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The company maintains a significant federal procurement presence across the Defense Health Agency and other government healthcare systems, demonstrating its critical role as a major pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 7/23/25 |